Biognosys

Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision-making.

Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys today is an established leader in next-generation proteomics. From our global headquarters just outside of Zurich, we operate one of the largest proteomics facilities worldwide and make the most advanced proteomics solutions available to life science researchers across industry and academia.